Alpine Global Management, LLC Absci Corp Transaction History

Alpine Global Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 06, 2024	BUY	$1.17 - $2.03 $56,672 - $98,329	48,438 New	48,438 $73,000
Q2 2023 Nov 21, 2023	BUY	$1.17 - $2.03 $56,672 - $98,329	48,438 New	48,438 $73,000
Q2 2023 Aug 14, 2023	BUY	$1.17 - $2.03 $56,672 - $98,329	48,438 New	48,438 $73,000
Q1 2022 May 13, 2022	SELL	$5.87 - $9.46 $93,931 - $151,378	-16,002 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.88 - $18.03 $126,095 - $288,516	16,002 New	16,002 $131,000

127

59.1M

255K

93.6K

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $238M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.